Company intelligence / Profile preview

Rose Hill Life Sciences

Runaway Bay (Rose Hill Estate), Jamaica

Ownership: Private
Development stage: Other

Overview

Rose Hill Life Sciences leads the industry as the world's first legal exporter of psilocybin, supplying standardized, traceable natural product for academic, clinical, and regulated market research. Supported by proprietary genetic strains and full-spectrum alkaloid profiling, the company partners with leading institutions for preclinical and early-phase human studies targeting mental health and neurological conditions (including novel licensed IP for motor function restoration after CNS injury)[5][6][10].

Therapeutic areas: NeurologyPsychiatry
Modalities: Natural productSmall moleculeExtractBiomass
Industry: Biotech

Partnerships

Johns Hopkins UniversityACS LaboratoryUniversity of Guelph

Beyond the preview

Go deeper on Rose Hill Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rose Hill Life Sciences.

Explore the full profile